| FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer N Turner, A Pearson, R Sharpe, M Lambros, F Geyer, MA Lopez-Garcia, ... Cancer research 70 (5), 2085-2094, 2010 | 819 | 2010 |
| Breast cancer precursors revisited: molecular features and progression pathways MA Lopez‐Garcia, FC Geyer, M Lacroix‐Triki, C Marchió, JS Reis‐Filho Histopathology 57 (2), 171-192, 2010 | 415 | 2010 |
| Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma MÁ Castilla, G Moreno‐Bueno, L Romero‐Pérez, KV De Vijver, ... The Journal of pathology 223 (1), 72-80, 2011 | 273 | 2011 |
| Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer KJ Dedes, R Natrajan, MB Lambros, FC Geyer, MA Lopez-Garcia, ... European journal of cancer 47 (1), 138-150, 2011 | 189 | 2011 |
| The molecular pathology of hereditary breast cancer J Palacios, MJ Robles Frías, MA Castilla, MA Lopez-Garcia, J Benitez Pathobiology 75 (2), 85-94, 2008 | 184 | 2008 |
| Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple‐negative and basal‐like breast cancers D Wetterskog, MA Lopez‐Garcia, MB Lambros, R A'Hern, FC Geyer, ... The Journal of pathology 226 (1), 84-96, 2012 | 183 | 2012 |
| The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐and molecular subtype‐matched … B Weigelt, FC Geyer, R Natrajan, MA Lopez‐Garcia, AS Ahmad, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010 | 174 | 2010 |
| MicroRNA-200 family modulation in distinct breast cancer phenotypes MÁ Castilla, J Díaz-Martín, D Sarrió, L Romero-Pérez, MÁ López-García, ... PloS one 7 (10), e47709, 2012 | 122 | 2012 |
| Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology R Colomer, I Aranda-López, J Albanell, T García-Caballero, E Ciruelos, ... Clinical and Translational Oncology 20, 815-826, 2018 | 91 | 2018 |
| Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases JT Geyer, MA López-García, C Sánchez-Estevez, D Sarrió, ... The American journal of surgical pathology 33 (8), 1157-1163, 2009 | 85 | 2009 |
| ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma L Romero-Pérez, MÁ López-García, J Díaz-Martín, M Biscuola, ... Modern Pathology 26 (11), 1514-1524, 2013 | 83 | 2013 |
| Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer J Diaz-Martin, MÁ López-García, L Romero-Perez, MR Atienza-Amores, ... Endocrine-related cancer 22 (3), 443-454, 2015 | 81 | 2015 |
| Pathologic and molecular features of uterine carcinosarcomas MA Lopez-Garcia, J Palacios Seminars in diagnostic pathology 27 (4), 274-286, 2010 | 81 | 2010 |
| PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study MB Lambros, R Natrajan, FC Geyer, MA Lopez-Garcia, KJ Dedes, ... Modern Pathology 23 (10), 1334-1345, 2010 | 72 | 2010 |
| The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers TM Abdel‐Fatah, DG Powe, J Agboola, M Adamowicz‐Brice, RW Blamey, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010 | 72 | 2010 |
| VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer MÁ Castilla, MÁ López-García, MR Atienza, JM Rosa-Rosa, J Díaz-Martín, ... Endocrine-related cancer 21 (4), 587-599, 2014 | 64 | 2014 |
| Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models L Melchor, G Molyneux, A Mackay, FA Magnay, M Atienza, H Kendrick, ... The Journal of pathology 233 (2), 124-137, 2014 | 59 | 2014 |
| Genetic characterization of breast cancer and implications for clinical management FC Geyer, MA Lopez‐Garcia, MB Lambros, JS Reis‐Filho Journal of cellular and molecular medicine 13 (10), 4090-4103, 2009 | 54 | 2009 |
| Biological properties of hydroxytyrosol and its derivatives JG Fernández-Bolaños, Ó López, MÁ López-García, A Marset Olive oil-constituents, quality, health properties and bioconversions, 2012 | 52 | 2012 |
| MAP17 and SGLT1 protein expression levels as prognostic markers for cervical tumor patient survival M Perez, JM Praena-Fernandez, B Felipe-Abrio, MA Lopez-Garcia, ... PLoS One 8 (2), e56169, 2013 | 50 | 2013 |
